Edition:
India

Misonix Inc (MSON.OQ)

MSON.OQ on NASDAQ Stock Exchange Global Market

10.55USD
2:29am IST
Change (% chg)

$0.00 (+0.00%)
Prev Close
$10.55
Open
$10.60
Day's High
$10.60
Day's Low
$10.55
Volume
2,287
Avg. Vol
2,926
52-wk High
$12.00
52-wk Low
$7.05

Summary

Name Age Since Current Position

Stavros Vizirgianakis

45 2016 President, Chief Executive Officer, Director

Joseph Dwyer

61 2017 Chief Financial Officer, Treasurer, Secretary

Robert Ludecker

48 2016 Senior Vice President - Global Sales and Marketing

Joseph Brennan

51 2014 Vice President - Operations

Chris Wright

Vice President - US Sales

John Salerno

60 2015 Vice President - Quality and Regulatory Affairs

Daniel Voic

53 2002 Vice President - Research & Development and Engineering

John Gildea

73 2004 Independent Director

Patrick McBrayer

63 2014 Independent Director

Charles Miner

64 2005 Independent Director

Thomas Patton

2015 Independent Director

Biographies

Name Description

Stavros Vizirgianakis

Mr. Stavros G. Vizirgianakis is an President, Chief Executive Officer, Director of the Company. He has a distinguished career in the medical devices arena having worked for US Surgical Corporation as director of sales for sub-Saharan Africa and later Tyco Healthcare in the capacity of General Manager South Africa. In 2006, Mr. Vizirgianakis co-founded Surgical Innovations, which has become one of the largest privately owned medical device distributors in the African region and now part of the Johannesburg Stock Exchange listed entity Healthcare Ascendis. Mr. Vizirgianakis is a strategic investor and advisor to numerous medical device startups and established companies in this arena. Mr. Vizirgianakis has a degree in commerce from the University of South Africa.

Joseph Dwyer

Mr. Joseph P. Dwyer is Chief Financial Officer, Treasurer, Secretary of the Company. From June 2015 to the present, Mr. Dwyer has provided financial consulting and advisory services to companies through Dwyer Co. Prior thereto, from November 2012 until June 2015, he was Chief Financial Officer of Virtual Piggy, Inc., a publicly-traded technology company (“Virtual Piggy”). Prior to joining Virtual Piggy, Mr. Dwyer served as chief financial officer of OpenLink Financial, Inc., a privately held company, which provides software solutions for trading and risk management in the energy, commodity, and capital markets. During 2011 and 2012, Mr. Dwyer was a member of the board of directors and chairman of the audit committee and served as interim chief administrative officer of Energy Solutions International, Inc. From 2010 through 2011, Mr. Dwyer served as chief administrative officer of Capstone Advisory Group, LLC. Mr. Dwyer served as a consultant to Verint Systems, Inc., a software company listed on the NASDAQ Global Market, from 2009 through 2010, assisting with SEC reporting and compliance. From 2005 through 2009, Mr. Dwyer served as chief financial officer and executive vice president of AXS-One Inc., a publicly traded software company. During 2004, Mr. Dwyer served as chief financial officer of Synergen, Inc. Prior to 2004, Mr. Dwyer also served as chief financial officer and executive vice president of Caminus Corporation, chief financial officer of ACTV, Inc., and chief financial officer of Winstar Global Products, Inc., a manufacturer and distributor of hair care, bath and beauty products until its acquisition by Winstar Communications, Inc. in 1995 when Mr. Dwyer went on to serve as senior vice president, finance of Winstar Communications. Mr. Dwyer received his BBA in Accounting from the University of Notre Dame in 1978 and is licensed as a Certified Public Accountant in the State of New York.

Robert Ludecker

Mr. Robert Scott Ludecker is Senior Vice President - Global Sales and Marketing of the Company. He has more than 20 years of experience in the global medical device industry, Scott Ludecker has a demonstrated track record of successfully commercializing medical technology and in building and managing global sales distribution networks. Mr. Ludecker most recently served as Vice President of Global Sales and Marketing for BioMimetic Therapeutics, a NASDAQ-listed biotechnology company, specializing in the development and commercialization of products which promote the healing of musculoskeletal injury and diseases, including orthopedic, spine, and sports medicine applications. Mr. Ludecker is a graduate of Kenyon College with a Bachelor of Arts degree.

Joseph Brennan

Mr. Joseph Brennan is Vice President - Operations of the Company. Prior to joining the Company, He joined Misonix Corporation in August of 2014 as Vice President of Operations. Most recently, he served as Director of Operations for Air Techniques Inc., a vertically integrated manufacturer of air products for the dental operatory and digital imaging products for dental, medical and veterinary applications. Mr. Brennan has 30 years of diversified manufacturing experience. He holds degrees in Mechanical Engineering and Manufacturing Engineering from Farmingdale State University.

Chris Wright

Mr. Chris Wright is Vice President - US Sales of the company. He has more than 15 years of experience in the medical device industry and has a proven record in building and managing sales teams, product launches, and commercializing medical technology. Prior to being the VP of US Sales Mr. Wright was Misonix’s National Sales Director overseeing the Spine and Neuro sales activities. In his last role Mr. Wright was the Eastern US Sales Director for Biomimeitcs ( BMTI, NASDAQ) before being purchased by Wright Medical Technology ( WMGI, NASDAQ). Prior to Biomimetics Mr. Wright has held various ascending management and sales roles in startup medical device companies and Fortune 500 companies. Mr. Wright is a graduate of Xavier University of Louisiana with degrees in History and Business Administration.

John Salerno

Mr. John J. Salerno is Vice President - Quality and Regulatory Affairs of the company. He has over 35 years of experience in quality assurance, quality engineering, quality systems, regulatory compliance and regulatory affairs for the pharmaceutical, medical device, in-vitro diagnostic and cosmetic industries. He has held senior positions with International Technidyne Division of Thoratec Corporation, Pall Corporation and Rugby-Darby Group Companies and has consulted for Becton Dickinson Corporation, Bausch and Lomb Corporation and Novartis. Mr. Salerno holds a B.S. in Biology from Fordham University and a M.S. in Microbiology from Long Island University.

Daniel Voic

Mr. Daniel Voic is Vice President - Research and Development and Engineering of the Company. Prior thereto, he served as Engineering Manager and Director of Engineering with the Company. Mr. Voic has approximately 14 years experience in both medical and laboratory and scientific products development. Mr. Voic holds a M.S. degree in mechanical engineering from Polytechnic University "Traian Vuia" of Timisoara, Romania and a MS degree in applied mechanics from Polytechnic University of New York.

John Gildea

Mr. John W. Gildea is Independent Director of the Company. He is the founding principal of Gildea Management Co., a management company of special situations with middle market companies in the United States and Central Europe. From 2000 to 2003 Gildea Management Co. formed a joint venture with F. O. Hambro Capital Management Co. to manage accounts targeting high yield debt and small capitalization equities. From 1996 to 2000 Gildea Management Co. formed and founded Latona Europe, a joint venture between Latona U.S., Lazard Co., and Gildea Management Co. to restructure several Czech Republic companies. Before forming Gildea Management Co. in 1990, Mr. Gildea managed the Corporate Series Group at Donaldson, Lufkin and Jenrette, an investment banking firm. Mr. Gildea is a graduate of the University of Pittsburgh.

Patrick McBrayer

Mr. Patrick A. McBrayer is Independent Director of the Company since September 29, 2014. He has served as President and Chief Executive Officer and as a director of privately-held AxioMed Spine Corporation (“AxioMed”) from February 2006 to the present time. AxioMed is a medical device company focused on restoring the natural function of the spine. Prior to joining AxioMed, he held positions with Xylos Corporation (medical biomaterials); Exogen, Inc. (treatment of musculoskeletal injury and disease); Osteotech, Inc. (tissue technology); and Johnson and Johnson Products, Inc. (healthcare products). Mr. McBrayer holds a B. S. in General Engineering fom the United States Military Academy.

Charles Miner

Dr. Charles Miner, III, is Independent Director of Misonix, Inc. He has practiced internal medicine for over 25 years and presently has a private practice in Darien, Connecticut. He is on staff at Stamford Hospital and Norwalk Hospital, and holds a teaching position at Columbia Presbyterian Hospital. For the past ten years, Dr.Miner has also been Medical Director at Courtland Gardens Health Center, and, from 1990 through 2004, served as Medical Director of on-line health and wellness services for Lifecare, Inc., one of the largest privately owned employee benefits organizations in the U.S. and the exclusive provider of Life Event Management® Services. A graduate of the University of Cincinnati College of Medicine, Dr. Miner earlier studied molecular genetics at Columbia University and completed undergraduate work by receiving a Bachelor of Science from Lehigh University. Following medical school, Dr. Miner completed a medical internship and residency at Lennox Hill Hospital in New York City. In 1982, he was appointed as a Diplomat of the American Board of Internal Medicine.

Thomas Patton

Mr. Thomas M. Patton is Independent Director of the Company. He has been the President and Chief Executive Officer of CAS Medical Systems, Inc. since August 27, 2010. Mr. Patton joined the CAS on August 27, 2010. He serves as the Chairman and President at Informed Medical Communications (IMC). He was an Advisor at Ferrer Freeman & Company, LLC (FFC). Prior to this, he served as an Interim Chief Executive Officer at IMC from 2006 to 2007. He has been a Co-Founder, President, and Chief Executive Officer at QDX, Inc. since January 2003. He is also a Principal at Vista Advisors, LLC since April 2004. He was the President and Chief Operating Officer at Novametrix Medical Systems, Inc. from May 2000 to April 2004. Mr. Patton served as the President, Chief Executive Officer, General Counsel and Executive Vice President of Business Development at Wright Medical Technology, Inc., from November 1993 to March 2003 where he led a successful turnaround of Wright and orchestrated its recapitalization led by Warburg Pincus. He has been a Director of CAS Medical Systems Inc. since August 27, 2010. He has been a Member of the Board at Genova Diagnostics; OrthoRX; and Activus Healthcare Solutions, Inc., amongst other FFC companies. He also served on the Board of Osteotech Inc. since December 1, 2004. He served as a Director at K2M. Prior to joining Wright Medical, Mr. Patton served as a Litigation Attorney at Williams and Connolly in Washington D C. from 1989 to 1993. He graduated magna cum laude from Georgetown University Law Center and a B.A. degree from the College of the Holy Cross in Economics and Accounting.